| AUC (95% CI) | ACC | SEN | SPE | PPV | NPV |
---|---|---|---|---|---|---|
Model-Clinical | ||||||
 Training | 0.674 (0.543–0.804) | 0.694 | 0.795 | 0.536 | 0.729 | 0.625 |
 Testing | 0.847 (0.612–0.950) | 0.710 | 0.579 | 0.917 | 0.917 | 0.579 |
Model-CP | ||||||
 Training | 0.802 (0.693–0.911) | 0.792 | 0.818 | 0.750 | 0.837 | 0.724 |
 Testing | 0.781 (0.612–0.950) | 0.742 | 0.737 | 0.750 | 0.824 | 0.643 |
Model-IMD | ||||||
 Training | 0.871 (0.793–0.950) | 0.792 | 0.818 | 0.750 | 0.837 | 0.724 |
 Testing | 0.759 (0.582–0.936) | 0.774 | 0.790 | 0.750 | 0.833 | 0.692 |
Model-CP–IMD | ||||||
 Training | 0.900 (0.830–0.971) | 0.861 | 0.818 | 0.927 | 0.947 | 0.765 |
 Testing | 0.851 (0.711–0.991) | 0.839 | 0.842 | 0.833 | 0.889 | 0.769 |
Model-Combine | ||||||
 Training | 0.910 (0.837–0.983) | 0.875 | 0.955 | 0.750 | 0.857 | 0.913 |
 Testing | 0.912 (0.778–1.000) | 0.936 | 0.747 | 0.917 | 0.974 | 0.917 |